Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | Director | May 28, 2025 | May 30, 2025 |
| GENERAL ELECTRIC COGE · Entity 2813 | Director | January 03, 2023 | January 05, 2023 |
| ORACLE CORPORCL · Entity 2805 | Director | May 31, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GE HealthCare Technologies Inc.
Report date May 28, 2025 · Filed May 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 9,116 |
Reported balance
After 2025-05-28 transaction · row 1
1 source rowRow 1 · 2025-05-28 · Grant · Acquired 3,092 · Balance 9,116 F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
GENERAL ELECTRIC CO
Report date January 03, 2023 · Filed January 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Fee Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,678 |
Reported balance
After 2023-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-03 · Grant · Acquired 519 · Balance 1,678 F1: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan. F2: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock. F3: Payable beginning one year after termination of service as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan.
F2: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock.
F3: Payable beginning one year after termination of service as a director.
ORACLE CORP
Report date May 31, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,550 |
Reported balance
After 2026-05-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-31 · Grant · Acquired 1,550 · Balance 1,550 F1: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2: Restricted stock units vest 100% on first anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F2: Restricted stock units vest 100% on first anniversary of grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2026 Filed Jun 2, 2026 21:43 UTC | ORACLE CORP ORCL · Entity 2805 | GrantRestricted Stock Unit · Derivative | 1,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001341439-26-000050 · form4.xml · derivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,550 Underlying: Common Stock · 1,550 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest 100% on first anniversary of grant date. F2 · derivative.expiration_date: Restricted stock units vest 100% on first anniversary of grant date. Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:50 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028688 · wk-form4_1748641790.xml · nonDerivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,116 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 28, 2026. Settlement of vested restricted stock units may be deferred by the reporting person, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:34 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024971 · wk-form4_1716496434.xml · nonDerivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,024 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:32 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 3,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-019791 · wf-form4_168504672341127.xml · nonDerivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,584 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 23, 2024. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:48 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantDeferred Fee Phantom Stock Units · Derivative | 559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001115 · doc4.xml · derivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559 Underlying: Common stock, par value $0.01 per share · 559 shares Expires not disclosed F1 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare Technologies Inc. ("GE HealthCare"). F2 · price: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.exercise_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. F2 · derivative.expiration_date: Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 22:12 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 519 | $82.41 | $42,770.79 |
DisclosureSEC source: 0000040545-23-000010 · wf-form4_167295674604962.xml · derivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,678 Underlying: Common Stock · 519 shares Expires not disclosed F1 · security: Acquired at a price of $82.41 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of the issuer's common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| October 01, 2022 Filed Oct 4, 2022 21:09 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 627 | $68.21 | $42,767.67 |
DisclosureSEC source: 0001062993-22-020366 · form4.xml · derivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,158 Underlying: Common Stock · 627 shares Expires not disclosed F1 · security: Acquired at a price of $68.21 per unit pursuant to the terms of the 2022 Long-Term Incentive Plan. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:03 UTC | GENERAL ELECTRIC CO GE · Entity 2813 | GrantDeferred Fee Phantom Stock Units · Derivative | 532 | $69.53 | $36,989.96 |
DisclosureSEC source: 0001062993-22-016080 · form4.xml · derivative · entry 1 Mihaljevic Tomislav · CIK 0001917584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532 Underlying: Common Stock · 532 shares Expires not disclosed F1 · security: Acquired at a price of $69.53 per unit pursuant to the terms of the 2007 Long-Term Incentive Plan. F2 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F3 · derivative.exercise_date: Payable beginning one year after termination of service as a director. F3 · derivative.expiration_date: Payable beginning one year after termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.